Roche is looking to a busy 2026…
Roche is looking to a busy 2026 after 10 new [...]
Two and a half years after Sanofi…
Two and a half years after Sanofi unveiled to investors [...]
Roche has waved goodbye to an…
Roche has waved goodbye to an inflammation drug from Kiniksa—as [...]
AstraZeneca has outlined plans to…
AstraZeneca has outlined plans to invest $15 billion in China [...]
With a third consecutive year of…
With a third consecutive year of sales growth under its [...]
Ro is bringing Serena Williams to…
Ro is bringing Serena Williams to the Super Bowl. Months [...]
A brain tumor has prompted the FDA…
A brain tumor has prompted the FDA to put clinical [...]
With Cellares preparing to begin…
With Cellares preparing to begin commercial-stage production in 2027, the [...]
CalciMedica’s stock nosedived…
CalciMedica’s stock nosedived after the biotech abandoned a phase 2 [...]
Boehringer Ingelheim has shared…
Boehringer Ingelheim has shared more phase 2 data on its [...]